Table 1.
Control (16) | Uremia (16) | p-value | |
---|---|---|---|
Male: Female (Number) | 10:6 | 12:4 | 0.704 |
Age (years) | 53.8 ± 3.1 | 55.8 ± 1.9 | 0.527 |
BMI (Kg/m2) | 22.3 ± 0.3 | 22.2 ± 0.5 | 0.917 |
BUN (mg/dl) | 17 ± 0.6 | 66.9 ± 5.4 | <0.001 |
Creatinine (mg/dl) | 0.7 ± 0.1 | 10.5 ± 0.6 | <0.001 |
HS-CRP (mg/dl)a | 0.10 ± 0.01 | 0.45 ± 0.05 | <0.001 |
Total Cholesterol (mg/dl) | 163.7 ± 7.8 | 183.4 ± 5.8 | 0.052 |
Triglyceride (mg/dl) | 79.6 ± 9.9 | 161.5 ± 15.1 | <0.001 |
HDL-c (mg/dl) | 56.6 ± 2.2 | 38.6 ± 2.1 | <0.001 |
LDL-c (mg/dl) | 90.6 ± 5.1 | 98.2 ± 5.5 | 0321 |
Paraoxonase activity (nmol/min/100 μg) | 694 ± 23 | 517 ± 18 | <0.001 |
Arylesterase activity (μmol/min/50 μg) | 194 ± 6 | 118 ± 5 | <0.001 |
Lactonase activity (μmol/min/20 μg) | 107 ± 4 | 81 ± 3 | <0.001 |
BMI, body mass index; BUN, blood urea nitrogen; HS-CRP, high sensitive C-reactive protein; HDL-c, high-density lipoprotein-cholesterol; LDL-c, low-density lipoprotein-cholesterol.
Reference level of HS-CRP, (<0.8 mg/dl).